Insider Transactions in Q2 2022 at Recursion Pharmaceuticals, Inc. (RXRX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 18
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$15,000
$6.71 P/Share
|
|
Apr 18
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
|
Apr 18
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
35,836
-4.34%
|
$215,016
$6.85 P/Share
|
|
Apr 18
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
18,500
+4.28%
|
-
|
|
Apr 18
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
44,010
+9.65%
|
$88,020
$2.48 P/Share
|
|
Apr 14
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$17,500
$7.51 P/Share
|
|
Apr 14
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
|
Apr 14
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
34,517
-4.48%
|
$241,619
$7.57 P/Share
|
|
Apr 14
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
18,500
+4.57%
|
-
|
|
Apr 14
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
44,010
+10.28%
|
$88,020
$2.48 P/Share
|
|
Apr 08
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$15,000
$6.7 P/Share
|
|
Apr 08
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
|
Apr 08
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,920
-5.15%
|
$221,520
$6.59 P/Share
|
|
Apr 08
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
18,500
+4.91%
|
-
|
|
Apr 08
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
44,010
+10.93%
|
$88,020
$2.48 P/Share
|
|
Apr 07
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$15,000
$6.51 P/Share
|
|
Apr 07
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
|
Apr 07
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,718
-5.51%
|
$220,308
$6.55 P/Share
|
|
Apr 07
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
18,500
+5.26%
|
-
|
|
Apr 07
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
44,010
+11.68%
|
$88,020
$2.48 P/Share
|
|
Apr 06
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$15,000
$6.56 P/Share
|
|
Apr 06
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
|
Apr 06
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
35,826
-5.84%
|
$214,956
$6.78 P/Share
|
|
Apr 06
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
18,500
+5.68%
|
-
|
|
Apr 06
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
44,010
+12.57%
|
$88,020
$2.48 P/Share
|
|
Apr 05
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$17,500
$7.32 P/Share
|
|
Apr 05
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
|
Apr 05
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
34,472
-6.17%
|
$241,304
$7.45 P/Share
|
|
Apr 05
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
18,500
+6.19%
|
-
|
|
Apr 05
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
44,010
+13.67%
|
$88,020
$2.48 P/Share
|
|
Apr 01
2022
|
Dean Y Li Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,544
+0.26%
|
-
|
|
Apr 01
2022
|
R. Martin Chavez Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,438
+18.0%
|
-
|
|
Apr 01
2022
|
Terry Ann Burrell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,788
+1.29%
|
-
|
|
Apr 01
2022
|
Blake Borgeson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,300
+0.02%
|
-
|
|
Apr 01
2022
|
Zachary Bogue Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,382
+33.43%
|
-
|